Study examines best time to screen for sleep apnea after heart attack

March 8, 2017, American College of Cardiology

Conducting a diagnostic sleep test shortly after a heart attack can help doctors rule out sleep apnea, a form of disordered breathing during sleep, in patients, but tests conducted in the immediate aftermath of a heart attack are somewhat unreliable for positively diagnosing sleep apnea, according to results from a single-center study scheduled for presentation at the American College of Cardiology's 66th Annual Scientific Session. As a result, it may be best to repeat the test after a few months or to delay initial testing before making a definitive diagnosis and initiating treatment.

Sleep apnea is estimated to affect up to 18 million Americans, but it is often undiagnosed and untreated. Common signs include daytime sleepiness, heavy snoring and pauses in breathing during . The disorder increases cardiovascular risk, and in people who have had a , is associated with increased risk for high blood pressure, subsequent heart attack, stroke, heart failure and death.

"In view of the strong association between sleep disordered breathing and heart attack and the established negative prognostic implications of untreated sleep apnea in these patients, cardiologists are becoming increasingly aware of the importance of screening for sleep disorders in their daily practice," said Jeanette Ting, MB, ChB, senior resident at National University Heart Centre, Singapore, and the study's lead author. "Our aim was to determine if the screening should be performed during the acute phase soon after a heart attack or after a period of stabilization."

Sleep apnea is thought to contribute to cardiovascular disease by increasing stress on the heart and blood vessels, causing inflammation, reducing available oxygen and affecting hormones. Doctors can use questionnaires to identify patients who might have sleep apnea, but the only definitive test is an overnight sleep study, in which a specialist uses electrodes and sensors to monitor how often the patient stops breathing during sleep and the length of each pause.

For the study, researchers performed an overnight sleep test in 397 patients treated for heart attack at Singapore's National University Heart Center. This initial test was conducted within five days of hospital admission. A subgroup of 102 patients underwent a second sleep test at home six months later.

A total of 52 percent of patients tested positive for sleep apnea in the initial test. Forty-two percent had , the most common form of the disorder, in which the airway is blocked for brief periods by the tongue or throat muscles. Ten percent had central sleep apnea, a less common form in which the brain fails to properly signal the muscles that control breathing.

About a quarter of the patients underwent a second sleep study after six months. A majority of the patients initially found to have sleep apnea showed a change of status in the follow-up sleep study. Among those initially diagnosed with obstructive sleep apnea, 46 percent no longer had sleep apnea at the 6-month test. Among those initially diagnosed with central sleep apnea, 83 percent were found to have obstructive sleep apnea at the 6-month test. The vast majority (93 percent) of those initially found to have no sleep apnea remained apnea-free at six months.

Overall, patients with sleep apnea were older, had a higher body mass index and more often had high blood pressure compared to those without sleep apnea. Patients showed no significant change in body mass index between the first and second sleep tests.

Mild sleep apnea can sometimes be resolved with weight loss, exercise, smoking cessation, management of allergies or asthma, or a change of sleeping position. For moderate to severe sleep apnea, many patients need to use a continuous positive airway pressure (CPAP) machine, which involves placing a mask over the mouth and nose during sleep to provide a continuous flow of air into their throat. Other treatment options include night-time mouthpieces and, as a last resort, surgery to remove bulky tissues obstructing the airway during sleep. These treatments have been shown to reduce the cardiovascular risk associated with sleep apnea.

The study bolsters evidence from previous smaller studies suggesting sleep apnea diagnosed immediately after a heart attack may resolve naturally over time. In addition, because different types of sleep apnea may require different treatments, the change in apnea type observed in this study underscores the need for repeated or delayed testing after the initial hospitalization for a heart attack. Finding the optimal timing to screen for sleep apnea is important because of the need to avoid unnecessary treatment in people whose sleep apnea may resolve over time, while identifying those who truly need to receive treatment to reduce their cardiovascular risk. Making accurate sleep apnea diagnoses also has a bearing on health care costs.

"It is important to determine if the patient truly has underlying ," Ting said. "A repeat sleep study six months later on those found to have obstructive sleep apnea or central sleep apnea should be considered before commencing therapy. Alternatively, deferring the sleep study to six months' follow-up may be considered."

The study was limited by a small sample size. In addition, the baseline sleep study was conducted at the hospital while the second sleep study was performed at the patients' home, which could have influenced the findings. The researchers plan to further analyze the data to assess how sleep apnea might affect measures of heart function.

Ting will present the study, "Prevalence and Evolution of Sleep Disordered Breathing in Acute Myocardial Infarction," on Sunday, March 19, at 9:30 a.m. ET at Poster Hall C at the American College of Cardiology's 66th Annual Scientific Session in Washington. The meeting runs March 17-19.

Explore further: Study finds no link between sleep apnea and joint pain

Related Stories

Study finds no link between sleep apnea and joint pain

August 1, 2016
Consistent with previous reports, poor sleep quality was linked with joint pain in a recent Arthritis Care & Research study of the general population, but the study found no association between obstructive sleep apnea and ...

Hard-to-treat hypertension may jeopardize sleep apnea patients' heart health

July 18, 2016
In a study of patients with hypertension, those with resistant hypertension—meaning that their blood pressure remained elevated despite concurrent use of three antihypertensive agents of different classes—had a higher ...

Sleep apnea treatment may reverse unhealthy brain changes

September 15, 2015
(HealthDay)—Sleep apnea treatment may reverse changes in brain stem activity associated with increased risk of heart disease, a new study suggests.

Sleep apnea immediately compromises blood pressure

November 17, 2016
A single bout of sleep apnea impacts the human body's ability to regulate blood pressure.

Sleep apnea may raise heart risks in people with pacemakers

May 5, 2016
(HealthDay)—People with heart pacemakers and sleep apnea are at much greater risk for a dangerous heart rhythm disorder called atrial fibrillation, a new study suggests.

Study finds that CPAP therapy reduces acid reflux in people with sleep apnea

October 3, 2016
A new study suggests that CPAP therapy may help improve the symptoms of nocturnal gastroesophageal reflux in patients with obstructive sleep apnea.

Recommended for you

Sleep apnea, congenital heart disease may be deadly mix for hospitalized infants

September 17, 2018
Infants often aren't screened for sleep apnea, but a new study suggests the disorder may be tied to an increased risk of death in infants with congenital heart disease.

Sleep deficiency increases risk of a motor vehicle crash

April 4, 2018
Excessive sleepiness can cause cognitive impairments and put individuals at a higher risk of motor vehicle crash. However, the perception of impairment from excessive sleepiness quickly plateaus in individuals who are chronically ...

Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms

March 13, 2018
Researchers from the UCLA School of Nursing examined clinical records and magnetic resonance imaging brain scans of patients who were recently diagnosed with sleep apnea, and discovered several apparent connections between ...

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.